Literature DB >> 18975357

Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample.

Nicoletta Solari1, Stefania Viola, Angela Pistorio, Silvia Magni-Manzoni, Rosa Vitale, Nicolino Ruperto, Nicola Ullmann, Giovanni Filocamo, Alberto Martini, Angelo Ravelli.   

Abstract

OBJECTIVE: To investigate the disease outcomes of a cross-sectional sample of children with longstanding juvenile idiopathic arthritis (JIA) seen between September 2002 and December 2006, and to provide a benchmarking of outcomes obtained with current treatment.
METHODS: All consecutive patients were included if they met the following criteria: diagnosis of JIA, disease duration > or = 5 years, and informed consent. Outcome assessments included disease activity, inactive disease, minimal disease activity, pain, physical function, health-related quality of life (HRQOL), auxometric measurements, and articular and extraarticular damage.
RESULTS: A total of 310 patients were included. At study visit, patients had on average a low level of disease activity. However, only 21.8% met the criteria for inactive disease, and less than 50% met the definition of minimal disease activity. Additionally, 19.2% had moderate to severe Childhood Health Assessment Questionnaire disability and 3.6% were in Steinbrocker class III-IV. Approximately 10% had major impairment in HRQOL. A total of 34.2% had damage in > or = 1 joint or joint group and 26.1% showed extraarticular damage. Of the 125 patients who underwent a wrist radiograph, 35.2% had significant structural damage and 8.7% had growth retardation.
CONCLUSION: Our patients had on average a low level of disease activity, little or no physical disability, and a satisfactory HRQOL. However, a sizable proportion of patients had persistently active disease, impaired function, and damage. These findings underscore the critical need for treatments and treatment strategies that have the ability to better control disease activity and to reduce the development of disease-related morbidities.

Entities:  

Mesh:

Year:  2008        PMID: 18975357     DOI: 10.1002/art.24202

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

2.  What does it mean to grow up with juvenile idiopathic arthritis? A qualitative study on the perspectives of patients.

Authors:  Leen Eyckmans; Deborah Hilderson; Rene Westhovens; Carine Wouters; Philip Moons
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

Review 3.  Remission in juvenile idiopathic arthritis: current facts.

Authors:  Susan Shenoi; Carol A Wallace
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

4.  The importance of visual function in the quality of life of children with uveitis.

Authors:  Sheila T Angeles-Han; Kenneth W Griffin; Thomas J A Lehman; John R Rutledge; Stephen Lyman; Joseph T Nguyen; Melanie J Harrison
Journal:  J AAPOS       Date:  2010-03-17       Impact factor: 1.220

Review 5.  Assessment and management of pain in juvenile idiopathic arthritis.

Authors:  Jennifer N Stinson; Nadia J C Luca; Lindsay A Jibb
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

6.  Burden of childhood-onset arthritis.

Authors:  Lakshmi N Moorthy; Margaret Ge Peterson; Afton L Hassett; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-08       Impact factor: 3.054

7.  Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Giovanni Filocamo; Stefano Lanni; Giulia Bracciolini; Marco Garrone; Silvia Scala; Luca Villa; Giuseppe Silvestri; Daniela Tani; Alessandra Zolesi; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-20       Impact factor: 3.054

8.  Current medical treatments for juvenile idiopathic arthritis.

Authors:  Nicolino Ruperto; Alberto Martini
Journal:  Front Pharmacol       Date:  2011-10-10       Impact factor: 5.810

9.  Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA).

Authors:  Philomine A van Pelt; Tim Takken; Marco van Brussel; Mirjam de Witte; Aike A Kruize; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-20       Impact factor: 3.054

10.  Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA).

Authors:  Philomien A van Pelt; Tim Takken; Marco van Brussel; Inge de Witte; Aike A Kruize; Nico M Wulffraat
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-27       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.